Alumis (ALMS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.12, -3.01% vs the prior close of $6.31.
- Volume 2.50M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALMS slides 3.0% to $6.12. Closed at $6.12, -3.01% vs the prior close of $6.31. Day range $6.01–$6.31, opened at $6.31.
ALMS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ALMS slides 3.0% to $6.12
- Closed at $6.12, -3.01% vs the prior close of $6.31. Day range $6.01–$6.31, opened at $6.31.
- Volume was 2.50M shares, 0.9x its 50-day average of 2.93M.
- Price is -54.9% vs its 50-day average ($13.57) and -72.1% vs its 200-day average ($21.91).
- 52-week range $4.37–$31.35; today's close sits at 6% of that range, 80.5% below the 52-week high.
Oct 15, 2026 — ALMS jumps 4.1% to $6.31
- Closed at $6.31, +4.13% vs the prior close of $6.06. Day range $6.08–$6.50, opened at $6.11.
- Volume was 2.79M shares, 1.0x its 50-day average of 2.89M.
- Price is -54.9% vs its 50-day average ($14.01) and -71.2% vs its 200-day average ($21.93).
- 52-week range $4.37–$31.35; today's close sits at 7% of that range, 79.9% below the 52-week high.
Oct 14, 2026 — ALMS slides 7.6% to $6.06, a 6-month low, 3 down days in a row
- Closed at $6.06, -7.62% vs the prior close of $6.56. Day range $6.01–$6.55, opened at $6.47.
- Volume was 2.30M shares, 0.8x its 50-day average of 2.86M.
- Price is -58.0% vs its 50-day average ($14.42) and -72.4% vs its 200-day average ($21.95).
- 52-week range $4.37–$31.35; today's close sits at 6% of that range, 80.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ALMS slides 7.1% to $6.56, a 6-month low
- Closed at $6.56, -7.08% vs the prior close of $7.06. Day range $6.53–$7.01, opened at $7.01.
- Volume was 1.90M shares, 0.7x its 50-day average of 2.85M.
- Price is -55.8% vs its 50-day average ($14.84) and -70.2% vs its 200-day average ($21.98).
- 52-week range $4.37–$31.35; today's close sits at 8% of that range, 79.1% below the 52-week high.
Oct 12, 2026 — ALMS dips 1.4% to $7.06
- Closed at $7.06, -1.40% vs the prior close of $7.16. Day range $6.97–$7.31, opened at $7.13.
- Volume was 1.60M shares, 0.6x its 50-day average of 2.84M — lighter than usual.
- Price is -53.7% vs its 50-day average ($15.23) and -67.9% vs its 200-day average ($22.00).
- 52-week range $4.28–$31.35; today's close sits at 10% of that range, 77.5% below the 52-week high.
Oct 9, 2026 — ALMS rises 2.7% to $7.16
- Closed at $7.16, +2.73% vs the prior close of $6.97. Day range $6.90–$7.28, opened at $7.04.
- Volume was 1.37M shares, 0.5x its 50-day average of 2.83M — lighter than usual.
- Price is -54.3% vs its 50-day average ($15.66) and -67.5% vs its 200-day average ($22.02).
- 52-week range $4.28–$31.35; today's close sits at 11% of that range, 77.2% below the 52-week high.
Oct 8, 2026 — ALMS rises 3.0% to $6.97
- Closed at $6.97, +2.95% vs the prior close of $6.77. Day range $6.61–$7.02, opened at $6.66.
- Volume was 2.85M shares, 1.0x its 50-day average of 2.79M.
- Price is -56.7% vs its 50-day average ($16.09) and -68.4% vs its 200-day average ($22.04).
- 52-week range $4.28–$31.35; today's close sits at 10% of that range, 77.8% below the 52-week high.
Oct 7, 2026 — ALMS dips 2.3% to $6.77, a 6-month low
- Closed at $6.77, -2.31% vs the prior close of $6.93. Day range $6.71–$6.95, opened at $6.82.
- Volume was 2.17M shares, 0.8x its 50-day average of 2.77M.
- Price is -58.9% vs its 50-day average ($16.48) and -69.3% vs its 200-day average ($22.07).
- 52-week range $4.08–$31.35; today's close sits at 10% of that range, 78.4% below the 52-week high.
Oct 6, 2026 — ALMS rises 1.3% to $6.93
- Closed at $6.93, +1.32% vs the prior close of $6.84. Day range $6.64–$6.95, opened at $6.89.
- Volume was 1.75M shares, 0.6x its 50-day average of 2.75M.
- Price is -59.0% vs its 50-day average ($16.89) and -68.6% vs its 200-day average ($22.09).
- 52-week range $3.96–$31.35; today's close sits at 11% of that range, 77.9% below the 52-week high.
Oct 5, 2026 — ALMS ends flat (-0.1%) to $6.84, a 6-month low, 3 down days in a row
- Closed at $6.84, -0.15% vs the prior close of $6.85. Day range $6.78–$7.17, opened at $6.99.
- Volume was 3.87M shares, 1.4x its 50-day average of 2.70M.
- Price is -60.4% vs its 50-day average ($17.29) and -69.1% vs its 200-day average ($22.11).
- 52-week range $3.96–$31.35; today's close sits at 10% of that range, 78.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — ALMS slides 5.0% to $6.85, a 6-month low
- Closed at $6.85, -4.99% vs the prior close of $7.21. Day range $6.64–$7.31, opened at $7.28.
- Volume was 2.62M shares, 1.0x its 50-day average of 2.66M.
- Price is -61.3% vs its 50-day average ($17.71) and -69.0% vs its 200-day average ($22.13).
- 52-week range $3.91–$31.35; today's close sits at 11% of that range, 78.1% below the 52-week high.
ALMS latest news & SEC filings
Every SEC filing by or about ALMS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Akkaraju Srinivas sold 48,066 shares at $10.55 (≈$507.10K) on Sep 8, 2026
- Akkaraju Srinivas bought 273,291 shares at $10.63 (≈$2.91M) on Sep 8, 2026
- Akkaraju Srinivas bought 273,290 shares at $10.63 (≈$2.91M) on Sep 8, 2026
- Akkaraju Srinivas sold 48,065 shares at $10.55 (≈$507.09K) on Sep 8, 2026
- Akkaraju Srinivas sold 48,066 shares at $10.55 (≈$507.10K) on Sep 8, 2026
- Akkaraju Srinivas bought 273,291 shares at $10.63 (≈$2.91M) on Sep 8, 2026
- …plus 18 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.66M (prior year $2.67M) (-37.7% vs Jun 30, 2025)
- Net income: -$142.22M (prior year $59.32M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.11 (prior year $0.77) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schroer John R. sold 3,282 shares at $26.37 (≈$86.55K) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ALMS
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 19, 2026, Jan 9, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.07% (largest 8.3%). That is a volatile stock.
- Liquidity: about 2.26M shares (≈$13.81M) trade per day on average.
- 52-week position: $6.12 vs a range of $4.37–$31.35 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 9 sales; latest: Srinivas Akkaraju sold 48,066 shares on Sep 8, 2026.
- Latest filings: 8-K Sep 1, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ALMS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.31 | 6.31 | 6.01 | 6.12 | 2.50M |
| Oct 15, 2026 | 6.11 | 6.50 | 6.08 | 6.31 | 2.79M |
| Oct 14, 2026 | 6.47 | 6.55 | 6.01 | 6.06 | 2.30M |
| Oct 13, 2026 | 7.01 | 7.01 | 6.53 | 6.56 | 1.90M |
| Oct 12, 2026 | 7.13 | 7.31 | 6.97 | 7.06 | 1.60M |
| Oct 9, 2026 | 7.04 | 7.28 | 6.90 | 7.16 | 1.37M |
| Oct 8, 2026 | 6.66 | 7.02 | 6.61 | 6.97 | 2.85M |
| Oct 7, 2026 | 6.82 | 6.95 | 6.71 | 6.77 | 2.17M |
| Oct 6, 2026 | 6.89 | 6.95 | 6.64 | 6.93 | 1.75M |
| Oct 5, 2026 | 6.99 | 7.17 | 6.78 | 6.84 | 3.87M |
| Oct 2, 2026 | 7.28 | 7.31 | 6.64 | 6.85 | 2.62M |
| Oct 1, 2026 | 7.40 | 7.48 | 7.15 | 7.21 | 2.13M |
| Sep 30, 2026 | 7.35 | 7.55 | 7.15 | 7.39 | 1.40M |
| Sep 29, 2026 | 7.16 | 7.41 | 7.13 | 7.29 | 1.67M |
| Sep 28, 2026 | 7.10 | 7.22 | 6.83 | 7.16 | 2.24M |
| Sep 25, 2026 | 7.33 | 7.38 | 7.03 | 7.10 | 1.72M |
| Sep 24, 2026 | 7.43 | 7.45 | 7.22 | 7.29 | 2.60M |
| Sep 23, 2026 | 8.03 | 8.07 | 7.31 | 7.44 | 2.69M |
| Sep 22, 2026 | 8.01 | 8.14 | 7.67 | 8.11 | 2.52M |
| Sep 21, 2026 | 7.82 | 7.92 | 7.56 | 7.90 | 2.43M |
About Alumis
Alumis (ALMS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1847367.
ALMS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Srinivas Akkaraju | Director | Sep 9, 2026 |
| Martin Babler | President, CEO and Chairman | Jan 28, 2026 |
| Patrick Machado | Director | Jul 2, 2026 |
| Sapna Srivastava | Director | Jul 2, 2026 |
| Lynn A. Tetrault | Director | Jul 2, 2026 |
| James B. Tananbaum | Director | Apr 3, 2026 |
| Zhengbin Yao | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Martin Babler | President, CEO and Chairman | Jan 28, 2026 |
| Mark Christopher Bradley | Chief Development Officer | Aug 5, 2026 |
| Jorn Drappa | Chief Medical Officer | Aug 5, 2026 |
| David M Goldstein | Chief Scientific Officer | Aug 5, 2026 |
| Roy C. Hardiman | Chief Business & Strategy Ofcr | Aug 5, 2026 |
| Sanam Pangali | Chief Legal Officer | Aug 5, 2026 |
| John R. Schroer | Chief Financial Officer | Aug 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,066 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,291 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,290 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,065 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,066 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,291 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,290 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,065 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,066 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,291 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,290 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,065 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Sale | 48,066 | $10.55 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,291 | $10.63 |
| Sep 8, 2026 | Srinivas Akkaraju | Buy | 273,290 | $10.63 |
ALMS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $24.05M | $-243.32M | -2.86 | $-369.52M |
| Dec 31, 2024 | — | $-294.23M | -10.38 | $-255.08M |
| Dec 31, 2023 | — | $-154.99M | -72.08 | $-129.97M |
Latest balance sheet: total assets $560.62M, total liabilities $108.46M, cash $63.71M (as of Jun 30, 2026).
ALMS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $24.41 |
| May 14, 2026 | 8-K Item 2.02 (results) | $24.63 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $25.38 |
| Jan 9, 2026 | 8-K Item 2.02 (results) | $19.56 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $5.28 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $4.42 |
| May 14, 2025 | 8-K Item 2.02 (results) | $4.51 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $4.37 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $6.59 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $10.81 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALMS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.